Host-directed therapies targeting the tuberculosis granuloma stroma

Pathogens and Disease
Elinor Hortle, Stefan H Oehlers

Abstract

Mycobacteria have co-evolved with their hosts resulting in pathogens adept at intracellular survival. Pathogenic mycobacteria actively manipulate infected macrophages to drive granuloma formation while subverting host cell processes to create a permissive niche. Granuloma residency confers phenotypic antimicrobial resistance by physically excluding or neutralising antibiotics. Host-directed therapies (HDTs) combat infection by restoring protective immunity and reducing immunopathology independent of pathogen antimicrobial resistance status. This review covers innovative research that has discovered 'secondary' symptoms of infection in the granuloma stroma are actually primary drivers of infection and that relieving these stromal pathologies with HDTs benefits the host. Advances in our understanding of the relationship between tuberculosis and the host vasculature, haemostatic system, and extracellular matrix reorganisation are discussed. Preclinical and clinical use of HDTs against these stromal targets are summarised.

References

Apr 1, 1975·Annals of Internal Medicine·A D Ginsburg
Apr 1, 1989·Proceedings of the National Academy of Sciences of the United States of America·C S HEG I Goldberg
Jun 1, 1985·Prostaglandins, Leukotrienes, and Medicine·P MadernaE Tremoli
Mar 1, 1972·Annals of Surgery·J Folkman
Jan 1, 1984·Experimental Lung Research·M Schuyler, W Forman
Apr 26, 1994·Proceedings of the National Academy of Sciences of the United States of America·R J D'AmatoJ Folkman
Mar 1, 1996·Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology : Official Publication of the International Retrovirology Association·J D KlausnerG Kaplan
Jun 1, 1996·British Journal of Haematology·S C RobsonP Jacobs
Jan 1, 1997·Tubercle and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease·A L MoreiraG Kaplan
Jan 7, 1999·The European Respiratory Journal·Y BüyükaşikS V Dündar
Jun 17, 2000·Infection and Immunity·V MonroyC Espitia
Jul 27, 2000·Tubercle and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease·H AungE A Rich
Sep 16, 2000·American Journal of Respiratory and Critical Care Medicine·W MatsuyamaM Osame
Dec 16, 2000·Digestive Diseases and Sciences·M R SouzaD R Borges
Aug 14, 2001·Infection and Immunity·M Quiding-JärbrinkG J Bancroft
Oct 20, 2001·Progress in Nucleic Acid Research and Molecular Biology·K Csiszar
Feb 11, 2003·Journal of Cellular Biochemistry·Herbert M Kagan, Wande Li
Jul 24, 2003·The American Journal of Pathology·Jun SatoFrancis J Castellino
May 28, 2004·Journal of Child Neurology·Johan F SchoemanGilla Kaplan
Jun 11, 2004·Chest·Füsun AlatasHüseyin Yildirim
Sep 15, 2004·Current Opinion in Cell Biology·Joni D Mott, Zena Werb
Mar 23, 2005·The Journal of Infection·P R DonaldJ F Schoeman
Dec 3, 2005·The Journal of Clinical Investigation·Meinrad GawazAndreas E May
Jan 13, 2006·Cardiovascular Research·Hideaki NagaseGillian Murphy
Apr 28, 2006·Nature·Janine T ErlerAmato J Giaccia
May 9, 2006·Cancer Metastasis Reviews·Alex Y Strongin
Nov 2, 2006·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Karin DaubMeinrad Gawaz
Dec 6, 2006·Antimicrobial Agents and Chemotherapy·Sean T ByrneYing Zhang
Dec 23, 2006·The Journal of Antimicrobial Chemotherapy·Sean T ByrneYing Zhang
May 2, 2007·Journal of Cellular Biochemistry·Stacey L PayneDawn A Kirschmann
Jun 19, 2007·American Journal of Respiratory Cell and Molecular Biology·Paul T ElkingtonJon S Friedland
Aug 30, 2008·Journal of the American College of Cardiology·Marco R Di TullioRalph L Sacco
Oct 10, 2008·Respiration; International Review of Thoracic Diseases·Georgina González-AvilaM Carmen Sarabia
Oct 15, 2009·Parasite Immunology·Z A Andrade
Nov 26, 2009·The Journal of International Medical Research·Tomaz VelnarV Smrkolj

❮ Previous
Next ❯

Citations

Jul 12, 2020·The FEBS Journal·Stefan H OehlersKristina M Cook
Oct 30, 2021·Molecular Microbiology·Monica Varela, Annemarie H Meijer

❮ Previous
Next ❯

Related Concepts

Related Feeds

Blood Clotting Disorders

Thrombophilia includes conditions with increased tendency for excessive blood clotting. Blood clotting occurs when the body has insufficient amounts of specialized proteins that make blood clot and stop bleeding. Here is the latest research on blood clotting disorders.

Related Papers

Journal of Microbiology and Biotechnology
Ye-Ram Kim, Chul-Su Yang
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
Alimuddin ZumlaHost-Directed Therapies Network (HDT-NET) Consortium
Frontiers in Immunology
Hlumani Ndlovu, Mohlopheni J Marakalala
© 2021 Meta ULC. All rights reserved